Concepedia
7
Publications
532
Citations
H-Index
2006
Active since
Affiliations
Emory University(Current)
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Pharmacyclics (United States)
Memorial Sloan Kettering Cancer Center
Temple University
Israel Arango‐Hisijara is an author at Emory University specializing in extracellular matrix, osteoarthritis, and osteoporosis.
Top concepts
MedicinePhysiologyOrthopedicsOsteoporosisOsteoarthritisExtracellular Matrix
Publications per year
2006–2021
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
Mary F. Barbe, Mario C. Rico, Salih Salihoglu et al. · Experimental Cell Research · 2008 · 140 citations
Sclerostin, Bone Morphogenic Protein, Physiology +7
Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study
Christian Buske, Alessandra Tedeschi, Judith Trotman et al. · Journal of Clinical Oncology · 2021 · 103 citations · Full text
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
Ariela Noy, Sven de Vos, Morton Coleman et al. · Blood Advances · 2020 · 94 citations · Full text
Osteoactivin acts as downstream mediator of BMP‐2 effects on osteoblast function
Samir M. Abdelmagid, Mary F. Barbe, Israel Arango‐Hisijara et al. · Journal of Cellular Physiology · 2006 · 75 citations · Full text
Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF‐β1‐induced extracellular matrix production in osteoblasts
John A. Arnott, Edem Nuglozeh, Mario C. Rico et al. · Journal of Cellular Physiology · 2006 · 62 citations
Rows per page
1–5 of 7